Millennium Management’s OnKure Therapeutics OKUR Stock Holding History

Millennium Management’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$126K	Buy	+30,499	New	+$94.2K	﹤0.01%	5302
2025 Q1	–	Sell	-144,099	Closed	-$1.24M	–	6536
2024 Q4	$1.24M	Buy	144,099 +132,042	+1,095%	+$2M	﹤0.01%	4024
2024 Q3	$205K	Buy	12,057 +1,058	+10%	+$15.7K	﹤0.01%	5437
2024 Q2	$166K	Buy	+10,999	New	+$186K	﹤0.01%	5203
2024 Q1	–	Sell	-15,889	Closed	-$254K	–	6745
2023 Q4	$254K	Buy	15,889 +3,620	+30%	+$226K	﹤0.01%	5052
2023 Q3	$934K	Buy	+12,269	New	+$834K	﹤0.01%	4234
2023 Q2	–	Sell	-2,394	Closed	-$143K	–	6793
2023 Q1	$143K	Sell	2,394 -912	-28%	-$33K	﹤0.01%	5297
2022 Q4	$77K	Sell	3,306 -437	-12%	-$11.6K	﹤0.01%	5658
2022 Q3	$125K	Sell	3,743 -2,226	-37%	-$73.1K	﹤0.01%	5885
2022 Q2	$158K	Buy	+5,969	New	+$139K	﹤0.01%	5750
2022 Q1	–	Sell	-2,499	Closed	-$214K	–	7601
2021 Q4	$214K	Buy	+2,499	New	+$184K	﹤0.01%	5853

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management's OKUR Position: Q1 2026 in Review

Millennium Management opened a new position in OnKure Therapeutics (OKUR) in Q1 2026: 30,499 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #5302 among its holdings. This is a return to the name: Millennium Management previously reported a position in OKUR as recently as Q4 2024.

Millennium Management first reported a position in OKUR in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.24M in Q4 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

Millennium Management held 30,499 shares of OnKure Therapeutics worth $126K as of Q1 2026.
OnKure Therapeutics was a new Millennium Management position in Q1 2026.
OnKure Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5302 holding.
Millennium Management first reported a position in OnKure Therapeutics in Q4 2021 and has held it in 11 quarters since.
Millennium Management's OnKure Therapeutics position peaked at $1.24M in Q4 2024.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.